Search This Blog

Thursday, June 2, 2022

Yumanity Therapeutics Sees Large Growth in Short Interest

 Yumanity Therapeutics, Inc. (NASDAQ:YMTX – Get Rating) was the recipient of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 138,000 shares, an increase of 25.5% from the April 30th total of 110,000 shares. Approximately 1.7% of the company’s shares are sold short. Based on an average daily trading volume, of 416,000 shares, the short-interest ratio is currently 0.3 days.

https://www.defenseworld.net/2022/06/01/yumanity-therapeutics-inc-nasdaqymtx-sees-large-growth-in-short-interest.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.